placement completed 8% premium, page-2

That's right apples.

This is a really really good indicator of their level of confidence. Transamine is no small potatoes in global commodities market. Plus their knowledge of Boseto and the global commodities market, this is as good of a thumbs up as any.

I am also betting that they are relieved that the Montsant deal did not go ahead. one of the thing Montsant asked for was a 50% of the off-take agreement. The Off take is worth a lot of money.

They are also aware that the upcoming rights issue would require them to tip in even more money at the end of the year.

I hope this will calm the nerves of jittery investors that DML is finished.

GLTA